<DOC>
	<DOCNO>NCT01533506</DOCNO>
	<brief_summary>The patient fail available agent intractable epilepsy due Dravet Syndrome . Stiripentol highly efficacious Dravet Syndrome . The overall goal therapy Stiripentol primarily significantly reduce frequency severity seizure .</brief_summary>
	<brief_title>Stiripentol Dravet Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Epilepsies , Myoclonic</mesh_term>
	<mesh_term>Stiripentol</mesh_term>
	<criteria>Genetic diagnosis Dravet syndrome intractable seizure despite fail available medication seizure</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>treatment stiripentol</keyword>
</DOC>